![Hanne Jensen](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Hanne Jensen
Directeur des opérations chez
CURASIGHT A/S
Fortune : 20 016 $ au 31/05/2026
Profil
Hanne Damgaard Jensen currently works at ROS-Therapeutics ApS, as Chief Executive Officer from 2018, Aimvion A, as Chairman from 2020, and Curasight A, as Chief Operating & Development Officer from 2022.
Ms. Jensen also formerly worked at Azanta A, as Chief Executive Officer from 2009 to 2017, Johnson & Johnson, as Principal, Novo Nordisk A, as Project Manager from 1995 to 1999, Genmab A, as Senior Vice President-Drug Development, and Roche Innovation Center Copenhagen A, as Senior Vice President-Product Development from 2007 to 2008.
Ms. Jensen received her Masters Business Admin degree from Copenhagen Business School, graduate degree from the University of Copenhagen, and Masters Business Admin degree from Scandinavian International Management Institute.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
CURASIGHT A/S 0,01% | 30/06/2025 | 6 929 ( 0,01% ) | 20 016 $ | 31/05/2026 |
Postes actifs de Hanne Jensen
| Sociétés | Poste | Début |
|---|---|---|
| CURASIGHT A/S | Directeur des opérations | 01/01/2022 |
ROS-Therapeutics ApS | Directeur Général | 01/01/2018 |
Aimvion A/S
 Aimvion A/S Pharmaceuticals: MajorHealth Technology Provides services for autoimmune diseases and biotechnology | Président | 01/01/2020 |
Anciens postes connus de Hanne Jensen
| Sociétés | Poste | Fin |
|---|---|---|
Azanta A/S
 Azanta A/S Pharmaceuticals: MajorHealth Technology Provides pharmaceutical drugs within oncology, women's healthcare, and addiction medicine | Directeur Général | 01/01/2017 |
Roche Innovation Center Copenhagen A/S
 Roche Innovation Center Copenhagen A/S Pharmaceuticals: MajorHealth Technology Discovers and develops drugs for the treatment of oncology, metabolic diseases, and infectious diseases | Corporate Officer/Principal | 01/01/2008 |
| GENMAB A/S | Corporate Officer/Principal | - |
| NOVO NORDISK A/S | Corporate Officer/Principal | 01/01/1999 |
| JOHNSON & JOHNSON | Corporate Officer/Principal | - |
Formation de Hanne Jensen
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
55
Relations au 1er degré
11
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 11 |
|---|---|
Johnson & Johnson
 Johnson & Johnson Pharmaceuticals: MajorHealth Technology Operates as an investment holding company with interests in health care products | Health Technology |
Novo Nordisk A/S
 Novo Nordisk A/S Pharmaceuticals: MajorHealth Technology Manufactures and markets pharmaceutical products for diabetes care | Health Technology |
Genmab A/S
 Genmab A/S BiotechnologyHealth Technology Operates as a biotechnology company for improving the lives of people with cancer and serious diseases through antibody medicines | Health Technology |
Copenhagen Business School
 Copenhagen Business School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Roche Innovation Center Copenhagen A/S
Roche Innovation Center Copenhagen A/S Pharmaceuticals: MajorHealth Technology Discovers and develops drugs for the treatment of oncology, metabolic diseases, and infectious diseases | Health Technology |
University of Copenhagen
 University of Copenhagen Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Scandinavian International Management Institute
 Scandinavian International Management Institute Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Azanta A/S
Azanta A/S Pharmaceuticals: MajorHealth Technology Provides pharmaceutical drugs within oncology, women's healthcare, and addiction medicine | Health Technology |
Curasight A/S
 Curasight A/S Medical SpecialtiesHealth Technology Provides PET imaging research techniques for prostate cancer | Health Technology |
Aimvion A/S
Aimvion A/S Pharmaceuticals: MajorHealth Technology Provides services for autoimmune diseases and biotechnology | Health Technology |
ROS-Therapeutics ApS |
